Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a publicly traded Healthcare sector company. As of July 22, 2026, SGMT trades at $7.25 with a market cap of $436.59M and a P/E ratio of -4.51. SGMT moved -0.28% today. Year to date, SGMT is +19.09%; over the trailing twelve months it is -26.56%. Its 52-week range spans $1.73 to $11.41. Analyst consensus is strong buy with an average price target of $28.44. Rallies surfaces SGMT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks SGMT insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $7.25 |
| Market Cap | $436.59M |
| P/E Ratio | -4.51 |
| EPS | $-1.58 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.41 |
| 52-Week Low | $1.73 |
| Volume | 708.50K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-51.04M |
| Gross Margin | 0.00% |
9 analysts cover SGMT: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $28.44.